Journal Section:
Commentary
References
1.
Byrne
RA
, Rossello
X
, Coughlan
JJ
, Barbato
E
, Berry
C
, Chieffo
A
, et al. 2023 ESC Guidelines for the management of acute coronary syndromes
. Eur Heart J
. 2023
;44
(38
):3720
–826
. 2.
Bergamaschi
L
, Foà
A
, Paolisso
P
, Renzulli
M
, Angeli
F
, Fabrizio
M
, et al. Prognostic role of early cardiac magnetic resonance in myocardial infarction with nonobstructive coronary arteries
. JACC Cardiovasc Imaging
. 2024
;17
(2
):149
–61
. 3.
Matter
MA
, Paneni
F
, Libby
P
, Frantz
S
, Stähli
BE
, Templin
C
, et al. Inflammation in acute myocardial infarction: the good, the bad and the ugly
. Eur Heart J
. 2024
;45
(2
):89
–103
. 4.
Angeli
F
, Ricci
F
, Moscucci
F
, Sciomer
S
, Bucciarelli
V
, Bianco
F
, et al. Sex- and gender-related disparities in chest pain syndromes: the feminine mystique of chest pain
. Curr Probl Cardiol
. 2024
;49
(4
):102457
. 5.
Fedele
D
, Cavallo
D
, Bodega
F
, Suma
N
, Canton
L
, Ciarlantini
M
, et al. Pathological findings at invasive assessment in MINOCA: a systematic review and meta-analysis
. Heart
. 2025
;111
(7
):291
–9
. 6.
Moreira
DM
, Lueneberg
ME
, da Silva
RL
, Fattah
T
, Gottschall
CAM
. MethotrexaTE THerapy in ST-segment elevation MYocardial InfarctionS: a randomized double-blind, placebo-controlled trial (TETHYS trial)
. J Cardiovasc Pharmacol Ther
. 2017
;22
(6
):538
–45
. 7.
Ridker
PM
, Everett
BM
, Pradhan
A
, MacFadyen
JG
, Solomon
DH
, Zaharris
E
, et al. Low-dose methotrexate for the prevention of atherosclerotic events
. N Engl J Med
. 2019
;380
(8
):752
–62
. 8.
Raimundo
GC
, Volpato Legat
L
, Medeiros Moreira
D
. Long-term effects of methotrexate on cardiovascular outcomes and left ventricular function in ST-segment elevation myocardial infarction: a five-year follow-up of the TETHYS trial
. Cardiology
. 2025
:1
–16
. 9.
Ridker
PM
, Everett
BM
, Thuren
T
, MacFadyen
JG
, Chang
WH
, Ballantyne
C
, et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease
. N Engl J Med
. 2017
;377
(12
):1119
–31
. 10.
Abbate
A
, Trankle
CR
, Buckley
LF
, Lipinski
MJ
, Appleton
D
, Kadariya
D
, et al. Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction
. J Am Heart Assoc
. 2020
;9
(5
):e014941
. 11.
Broch
K
, Anstensrud
AK
, Woxholt
S
, Sharma
K
, Tøllefsen
IM
, Bendz
B
, et al. Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction
. J Am Coll Cardiol
. 2021
;77
(15
):1845
–55
. 12.
Stähli
BE
, Klingenberg
R
, Heg
D
, Branca
M
, Manka
R
, Kapos
I
, et al. Mammalian target of rapamycin inhibition in patients with ST-segment elevation myocardial infarction
. J Am Coll Cardiol
. 2022
;80
(19
):1802
–14
. 13.
Bergamaschi
L
, Landi
A
, Maurizi
N
, Pizzi
C
, Leo
LA
, Arangalage
D
, et al. Acute response of the noninfarcted myocardium and surrounding tissue assessed by T2 mapping after STEMI
. JACC Cardiovasc Imaging
. 2024
;17
(6
):610
–21
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended...
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.